A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellul...
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
About this item
Full title
Author / Creator
Diesinger, Torsten , Lautwein, Alfred , Bergler, Sebastian , Buckert, Dominik , Renz, Christian , Dvorsky, Radovan , Buko, Vyacheslav , Kirko, Siarhei , Schneider, Edith , Kuchenbauer, Florian , Kumar, Mukesh , Günes, Cagatay , Genze, Felicitas , Büchele, Berthold , Simmet, Thomas , Haslbeck, Martin , Masur, Kai , Barth, Thomas , Müller-Enoch, Dieter , Wirth, Thomas and Haehner, Thomas
Publisher
Oakville: Hindawi
Journal title
Language
English
Formats
Publication information
Publisher
Oakville: Hindawi
Subjects
More information
Scope and Contents
Contents
Cytochrome P450 2E1 (CYP2E1) is a key target protein in the development of alcoholic and nonalcoholic fatty liver disease (FLD). The pathophysiological correlate is the massive production of reactive oxygen species. The role of CYP2E1 in the development of hepatocellular carcinoma (HCC), the final complication of FLD, remains controversial. Specifi...
Alternative Titles
Full title
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
Authors, Artists and Contributors
Author / Creator
Lautwein, Alfred
Bergler, Sebastian
Buckert, Dominik
Renz, Christian
Dvorsky, Radovan
Buko, Vyacheslav
Kirko, Siarhei
Schneider, Edith
Kuchenbauer, Florian
Kumar, Mukesh
Günes, Cagatay
Genze, Felicitas
Büchele, Berthold
Simmet, Thomas
Haslbeck, Martin
Masur, Kai
Barth, Thomas
Müller-Enoch, Dieter
Wirth, Thomas
Haehner, Thomas
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e74a70f467514028b4d33139a1dbe072
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e74a70f467514028b4d33139a1dbe072
Other Identifiers
ISSN
2291-2789
E-ISSN
2291-2797
DOI
10.1155/2021/8854432
